Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Summary

The purpose of this study is to determine the efficacy of ramelteon, once daily (QD), in subjects with mild to moderate Alzheimer's Disease and sleep disturbance

Timeline

Start

2006-03-21

Primary completion

2007-08-01

Completion

2007-08-20

Publications

• McCleery J, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2020 Nov 15;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub4.

Drugs

Indications